We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Skyepharma | LSE:SKP | London | Ordinary Share | GB00B3BFNB64 | ORD 100P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 443.00 | 0.00 | 00:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
TIDMSKP
RNS Number : 4415A
JPMorgan Securities Plc
07 June 2016
FORM 8.5 (EPT/RI)
PUBLIC DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITH RECOGNISED INTERMEDIARY STATUS DEALING IN A CLIENT-SERVING CAPACITY
Rule 8.5 of the Takeover Code (the "Code")
1. KEY INFORMATION (a) Name of exempt principal trader: J.P. Morgan Securities Plc ----------------------------------------------------------------------------------------- --------------------------- (b) Name of offeror/offeree in relation to whose relevant securities this form relates: Skyepharma PLC Use a separate form for each offeror/offeree ----------------------------------------------------------------------------------------- --------------------------- (c) Name of the party to the offer with which exempt principal trader is connected: Vectura Group PLC ----------------------------------------------------------------------------------------- --------------------------- (d) Date dealing undertaken: 06 June 2016 ----------------------------------------------------------------------------------------- --------------------------- (e) In addition to the company in 1(b) above, is the exempt principal trader making Yes disclosures Vectura Group PLC in respect of any other party to this offer? If it is a cash offer or possible cash offer, state "N/A" ----------------------------------------------------------------------------------------- --------------------------- 2. DEALINGS BY THE EXEMPT PRINCIPAL TRADER
Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(b), copy table 2(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.
The currency of all prices and other monetary amounts should be stated.
(a) Purchases and sales Class of relevant Purchases/ sales Total number of Highest price per unit Lowest price per unit security securities paid/received paid/received (GBP) (GBP) ----------------------- ----------------- ------------------------ ----------------------- ----------------------- Ordinary Shares Purchases 57,605 4.5014 4.4894 43,108 4.4950 4.4900 ----------------------- ----------------- ------------------------ ----------------------- ----------------------- (b) Cash-settled derivative transactions Class of relevant Product description Nature of dealing Number of reference Price per unit security e.g. CFD e.g. opening/closing a securities (GBP) long/short position, increasing/reducing a long/short position ------------------------- -------------------- ------------------------- ------------------------- --------------- Ordinary Shares Equity Swaps Short 270 4.4895 44,835 4.4922 12,500 4.5014 ------------------------- -------------------- ------------------------- ------------------------- --------------- (c) Stock-settled derivative transactions (including options) (i) Writing, selling, purchasing or varying Class of Product Writing, Number of Exercise price Type Expiry date Option relevant description purchasing, securities to per unit (GBP) e.g. money paid/ security e.g. call selling, which option American, received option varying relates European per unit etc. etc. (GBP) ------------- ------------- ------------ -------------- --------------- ------------- ------------ ------------ (ii) Exercise Class of relevant Product description Exercising/ exercised Number of securities Exercise price per security e.g. call option against unit (GBP) ----------------------- -------------------- ----------------------- --------------------- ----------------------- Ordinary Shares ----------------------- -------------------- ----------------------- --------------------- ----------------------- (d) Other dealings (including subscribing for new securities) Class of relevant security Nature of dealing Details Price per unit (if applicable) e.g. subscription, conversion (GBP) --------------------------- ------------------------------- -------- ------------------------------- (a) Indemnity and other dealing arrangements Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the exempt principal trader making the disclosure and any party to the offer or any person acting in concert with a party to the offer: Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state "none" ---------------------------------------------------------------------------------------------- None ---------------------------------------------------------------------------------------------- (b) Agreements, arrangements or understandings relating to options or derivatives Details of any agreement, arrangement or understanding, formal or informal, between the exempt principal trader making the disclosure and any other person relating to: (i) the voting rights of any relevant securities under any option; or (ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced: If there are no such agreements, arrangements or understandings, state "none" ----------------------------------------------------------------------------------------------- None ----------------------------------------------------------------------------------------------- Date of disclosure: 07 June 2016 --------------------- -------------- Contact name: Tung Le --------------------- -------------- Telephone number: 020 7742 7272 --------------------- --------------
Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service and must also be emailed to the Takeover Panel at monitoring@disclosure.org.uk. The Panel's Market Surveillance Unit is available for consultation in relation to the Code's dealing disclosure requirements on +44 (0)20 7638 0129.
The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.
This information is provided by RNS
The company news service from the London Stock Exchange
END
FERFRMMTMBBMBPF
(END) Dow Jones Newswires
June 07, 2016 06:21 ET (10:21 GMT)
1 Year Skyepharma Chart |
1 Month Skyepharma Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions